Documents disponibles écrits par cet auteur

Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe / Mereckiene J in Eurosurveillance. European communicable disease monthly [Euro Surveill], Vol. 17, N° 4 ([26/01/2012])  

[article]  inEurosurveillance. European communicable disease monthly [Euro Surveill] > Vol. 17, N° 4 [26/01/2012] . - pii=20064 Titre : Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe Type de document : Article scientifique Auteur(s) : Mereckiene J ; Cotter S ; Weber JT ; Nicoll A ; D'Ancona F ; Lopalco PL ; Johansen K ; Wasley AM ; Jorgensen P ; Levy Bruhl D ; Giambi C ; Stefanoff P ; Dematte L ; O Flanagan D ; the Vaccine European New Integrated Collaboration Effort (VENICE) project gatekeepers group Appartenance auteur(s) InVS DMI Année de publication : 2012 Article en page(s) : pii=20064 Langues : Anglais (eng) Mots-clés : Nouvelle grippe A (H1N1) ; Vaccination ; Politique vaccination ; Couverture vaccinale ; Union Européenne ; Norvège ; Islande Résumé : In August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization. (R.A.) PMID Pubmed : Pubmed : 22297139 Corpus : Grippe A(H1N1)/Production scientifique InVS Lien(s) externe(s) : http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20064 Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=10433 [article]

Documents numériques

10433_PS Adobe Acrobat PDF

Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage / Kanitz EE in Vaccine, Vol. 30, N° 35 ([27/07/2012])

[article]  inVaccine > Vol. 30, N° 35 [27/07/2012] . - 5222-8 Titre : Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage Type de document : Article scientifique Auteur(s) : Kanitz EE ; Wu LA ; Giambi C ; Strikas RA ; Levy Bruhl D ; Stefanoff P ; Mereckiene J ; Appelgren E ; D'Ancona F ; the Vaccine European New Integrated Collaboration Effort (VENICE) project gatekeepers group Appartenance auteur(s) InVS DMI Année de publication : 2012 Article en page(s) : 5222-8 Langues : Anglais (eng) Mots-clés : Vaccination ; Recommandation ; Politique vaccination ; Adulte ; Europe Résumé : Background: In 2010-2011, in the framework of the VENICE project, we surveyed European Union (EU) and Economic Area (EEA) countries to fill the gap of information regarding vaccination policies in adults. This project was carried out in collaboration with the United States National Vaccine Program Office, who conducted a similar survey in all developed countries. Methods: VENICE representatives of all 29 EU/EEA-countries received an online questionnaire including vaccination schedule, recommendations, funding and coverage in adults for 17 vaccine-preventable diseases. Results: The response rate was 100%. The definition of age threshold for adulthood for the purpose of vaccination ranged from 15 to 19 years (median = 18 years). EU/EEA-countries recommend between 4 and 16 vaccines for adults (median = 11 vaccines). Tetanus and diphtheria vaccines are recommended to all adults in 22 and 21 countries respectively. The other vaccines are mostly recommended to specific risk groups; recommendations for seasonal influenza and hepatitis B exist in all surveyed countries. Six countries have a comprehensive summary document or schedule describing all vaccines which are recommended for adults. None of the surveyed countries was able to provide coverage estimates for all the recommended adult vaccines. Conclusions: Vaccination policies for adults are not consistent across Europe, including the meaning of "recommended vaccine" which is not comparable among countries. Coverage data for adults should be collected routinely like for children vaccination. (R.A) PMID Pubmed : Pubmed : 22721901 Lien externe DOI : DOI : 10.1016/j.vaccine.2012.06.012 Corpus : Production scientifique InVS Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=10799 [article]